Full name
AUROVITAS PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
AUROVITAS PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. SOKRATESA 13D / 27, 01-909 WARSZAWA
TAX ID1182141800
Rate company:
AUROVITAS PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1182141800
KRS0000671478
Share capital9,150,900.00 zł
address
UL. SOKRATESA 13D / 27, 01-909 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1182141800
REGON
366934319
KRS
0000671478
Legal form
limited liability company
Register Address
UL. SOKRATESA 13D / 27, 01-909 WARSZAWA
Date of registration in KRS
2017-03-31
Date of commencement of economic activity
2017-03-31
Act signature
RDF/719836/25/654
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.38.Z - Wholesale trade of other food products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.75.Z - Wholesale trade
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
72.1 - Scientific research and development in natural and technical sciences
73.1 - Advertising
73.20.Z - Market research and public opinion polling
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
Payer VAT status
Active
Vat list bank account(s)
PL21 1030 1508 0000 0008 1711 0037 
PL97 1600 1462 1743 0884 7000 0002 PL70 1600 1462 1743 0884 7000 0003 PL27 1600 1462 1743 0884 7000 0001 PL66 1030 1508 0000 0008 1711 0003 PL39 1030 1508 0000 0008 1711 0004 PL93 1030 1508 0000 0008 1711 0002 Show more bank accounts from VAT list (4)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 17,8 | -20,8 | -22,5 | -8,2 |
EBITDA | 28,3 | -7,3 | -17 | -131,8 |
Short time liabilities | 74,6 | 71,4 | 40,4 | -43,4 |
Equity capital | 44,8 | 27,1 | 111,7 | 312,2 |
Operating profit (EBIT) | 20,1 | -15,8 | -25,5 | -61,2 |
Assets | 220,4 | 195,6 | 189,1 | -3,3 |
Net profit (loss) | 13,7 | -17,7 | -18,5 | -4,6 |
Cash | 8,4 | 18 | 10,1 | -43,8 |
Liabilities and provisions for liabilities | 175,6 | 168,5 | 77,4 | -54,1 |
Net income from sale | 238,3 | 206 | 199 | -3,4 |
Working assets | 182,5 | 160,6 | 148,8 | -7,3 |
Depreciation | 8,2 | 8,5 | 8,5 | 0,5 |
% | % | % | p.p. | |
Profitability of capital | 30,6 | -65,3 | -16,6 | 48,7 |
Equity capital to total assets | 20,3 | 13,9 | 59,1 | 45,2 |
Gross profit margin | 7,5 | -10,1 | -11,3 | -1,2 |
EBITDA Margin | 11,9 | -3,6 | -8,5 | -4,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 114 | 126 | 74 | -52 |
Current financial liquidity indicator | 2.2390248775482178 | 1.8527939319610596 | 2.4001498222351074 | 0,5 |
Net dept to EBITDA | 4.33668851852417 | -16.60007095336914 | -1.3604068756103516 | 15,2 |
Financial statements
01-04-2023 - 31-03-2024
Annual financial report
Download xades01-04-2023 - 31-03-2024
Annual financial report
Download pdf01-04-2023 - 31-03-2024
Activity report
Download pdf01-04-2023 - 31-03-2024
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-04-2023 - 31-03-2024
Resolution on profit distribution or loss coverage
Download pdf01-04-2023 - 31-03-2024
Resolution or decision approving the annual financial statements
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
TBK MEDICAL PARTNER
ŻYWIEC
"FARMEDICA" sp. z o.o.
Warszawa
HAMED Hurtownia sprzętu medycznego
Warszawa
APIOMEDYKA Zaopatrzenie Medyczne
Koszalin
ADO-MED Sp. z o.o.
Świętochłowice
Med Lux
Janów Lubelski